|Articles|November 21, 2022
Quality Control Analysis of Oligonucleotide Therapeutics: One Platform Method for Determining Identity, Purity, and Quantity
Author(s)Waters
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Genentech Expands RNAi Pipeline Through Global Licensing Deal
2
AdvanCell Targets GI Cancer With Peptide-Driven Lead-212 Radiotherapy
3
Pfizer Phase IIb Data Support Monthly GLP-1 Dosing for Obesity
4
Industry Outlook 2026: How AI and Payer Pressure Impact Biopharma R&D (Part 1)
5